Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, fondata nel 1982. In collaborazione con l'Associazione Culturale Pediatri.
Login Abbonamenti Pubblicazioni Carrello Registrazione Perché registrarsi? Contatti

Aggiornamento

Isolati, multipli, ereditari: le tante facce dei polipi intestinali

Isolated, multiple, and hereditary intestinal polyps in children

Chiara Pierobon1, Marta Flammini1, Valentina Moressa1,2, Stefano Martelossi2, Alessandro Ventura1,2

1Università di Trieste; 2IRCCS Materno-Infantile “Burlo Garofolo”, Trieste

Gennaio 2015 - pagg. 16 -24

Abstract
This article provides a critical review of the clinical presentation, pathology, genetics and management of the polyposis in childhood starting from the isolated juvenile polyp to the hereditary polyposis syndromes. These include the juvenile polyposis syndrome, Peutz-Jeghers syndrome, PTEN hamartoma tumor syndromes and familial adenomatous polyposis (FAP). These conditions typically outbreak in the second decade of life but early detection and proper screening and surveillance can minimize the risk of intestinal and extracolonic cancers. While juvenile polyp could be easily removed, the amartomatosis syndromes will require a specific endoscopic surveillance and a periodic polypectomy. In the case of FAP, the paediatrician has a decisive role in defining the colonscopic follow-up and the timing of the total colectomy.
Contenuto riservato

Per leggere l'articolo completo è necessario effettuare il login.

Non sei ancora registrato? Registrati

Bibliografia
1. Corredor J, Wambach J, Barnard J. Gastrointestinal polyps in children: Advances in molecular genetics, diagnosis, and managment. J Pediatr 2001;138:621-8. 2. Kliegman RM, Stanton BMD, St. Geme J, Schor N, Behrman RE. Nelson Textbook of Pediatrics, 19th Edition. 3. Bua J, Norbedo S, Martelossi S. Sangue e muco nelle feci. Medico e Bambino pagine elettroniche 2006;9(2). 4. Nugent KP, Talbot IC, Hodgson SV, Phillips RK. Solitary juvenile polyps: Not a marker for subsequent malignancy. Gastroenterology 1993;105:698-700. 5. Schreibman IR, Baker M, Amos C, McGarrity TJ. The hamartomatous polyposis syndromes: A clinical and molecular review. Am J Gastroenterol 2005;100:476-90. 6. Jass JR, Williams CB, Bussey HJ, Morson BC. Juvenile polyposis: a precancerous condition. Histopathology 1988;13:619-30. 7. Menko FH, Kneepkens CM, de Leeuw N, et al. Variable phenotypes associated with 10q23 microdeletions involving the PTEN and BMPR1A genes. Clin Genet 2008;74(2):145- 54. 8. Howe JR, Mitros FA, Summers RW. The risk of gastrointestinal carcinoma in familial juvenile polyposis. Ann Surg Oncol 1998;5:751-6. 9. Giardiello FM, Hamilton SR, Kern SE, et al. Colorectal neoplasia in juvenile polyposis or juvenile polyps. Arch Dis Child 1991;66:971-5. 10. Zbuk KM, Eng C. Hamartomatous polyposis syndromes. Nat Clin Pract Gastroenterol Hepatol 2007;4(9):492-502. 11. Aretz S, Stienen D, Uhlhaas S, et al. High proporation of large genomic deletions and a genotype phenotype update in 80 unrelated families with juvenile polyposis syndrome. J Med Genet 2007;44(11):702-9. 12. GeneTests. (Version current at November 9, 2006). 13. Lindor NM, McMaster ML, Lindor CJ, et al. Concise handbook of familial cancer susceptibility syndromes - second edition. J Natl Cancer Inst Monogr 2008;(38):1-93. 14. Katajisto P, Vallenius T, Vaahtomeri K, et al. The LKB1 tumor suppressor kinase in human disease. Biochim Biophys Acta 2007; 1775:63-75. 15. Noel RJ, Werlin SL. Peutz-Jeghers syndrome: are “shaggy” villi part of the pathology? Gastrointest Endosc 2008;68:1004-5. 16. Gammon A, Jasperson K, Kohlmann W, Burt RW. Hamartomatous polyposis syndromes. Best Pract Res Clin Gastroenterol 2009; 23:219-31. 17. Schreibman IR, Baker M, Amos C, Mc- Garrity TJ. The hamartomatous polyposis syndromes: a clinical and molecular review. Am J Gastroenterol 2005;100:476-90. 18. Lynch HT, Lynch JF, Lynch PM, Attard T. Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. Fam Cancer 2008;7:27- 39. 19. Vidal I, Podevin G, Piloquet H, et al. Follow- up and surgical management of Peutz-Jeghers syndrome in children. J Pediatr Gastroenterol Nutr 2009;48:419-25. 20. Mainetti M, Bevilacqua S, Vestri M, et al. Dolori addominali ricorrenti da invaginazione intermittente: un caso di sindrome di Peutz- Jeghers in una bambina di 13 anni. Medico e Bambino pagine elettroniche 2010;13(2). 21. Soares J, Lopes L, Vilas Boas G, Pinho C. Wireless capsule endoscopy for evaluation of phenotypic expression of small bowel polyps in patients with Peutz-Jeghers syndrome and in symptomatic first-degree relatives. Endo-scopy 2004;36:1060-6. 22. Joshi V. Peutz-Jeghers syndrome: a rare cause of gastric outlet obstruction. Clin Gastroenterol Hepatol 2009;7(11):A20. 23. O’Loughlin CJ, Taylor J, Karnam US, Garrido J. Pedunculated hamartomatous gastric polyp presenting with intermitent gastric outlet obstruction. Am J Gastroenterol 2002; 97:S210. 24. Kopacova M, Bures J, Vykouril L, et al. Intraoperative enteroscopy: ten years’ experience at a single tertiary center. Surg Endosc 2007;21:1111-6. 25. Lin BC, Lien JM, Chen RJ, Fang JF, Wong YC. Combined endoscopic and surgical treatment for the polyposis of Peutz-Jeghers syndrome. Surg Endosc 2000;14:1185-7. 26. Lim W, Hearle N, Shah B, et al. Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome. Br J Cancer 2003;89:308-13. 27. Hearle N, Schumacher V, Menko FH, et al. Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 2006;12:3209-15. 28. Li XB, Ge ZZ, Dai J, et al. The role of capsule endoscopy combined with double-balloon enteroscopy in diagnosis of small bowel diseases. Chin Med J (Engl) 2007;120:30-5. 29. Fry LC, Neumann H, Kuester D, et al. Small bowel polyps and tumours: endoscopic detection and treatment by double-balloon enteroscopy. Aliment Pharmacol Ther 2009;29 (1):135-42. 30. May A, Nachbar L, Schneider M, Neumann M, Ell C. Pushand-pull enteroscopy using the double-balloon technique: method of assessing depth of insertion and training of the enteroscopy technique using the Erlangen Endo-Trainer. Endoscopy 2005;37:66-70. 31. Gay G, Delvaux M, Frederic M. Capsule endoscopy in non-steroidal anti-inflammatory drugs-enteropathy and miscellaneous, rare intestinal diseases. World J Gastroenterol 2008; 14:5237-44. 32. Postgate A, Hyer W, Phillips R, et al. Feasibility of video capsule endoscopy in the management of children with Peutz-Jeghers syndrome: a blinded comparison with barium enterography for the detection of small bowel polyps. J Pediatr Gastroenterol Nutr 2009;49 (4):417-23. 33. Pennazio M, Rondonotti E, de Franchis R. Capsule endoscopy in neoplastic diseases. World J Gastroenterol 2008;14:5245-53. 34. Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000;119:1447-53. 35. Centuori S, Martellossi S, Ammar L. Storia di una famiglia con sindrome di Peutz-Jeghers: importanza dello screening strumentale anche nei soggetti asintomatici. Medico e Bambino pagine elettroniche 2003;6(9) l 36. Eng C. PTEN: one gene, many syndromes. Hum Mutat 2003;22(3):183-98. 37. Pilarski R, Eng C. Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet 2004;41(5):323-6. 38. Hildenbrand C, Burgdorf WH, Lautenschlager S. Cowden syndrome - diagnostic skin signs. Dermatology 2001;202(4):362-6. 39. Kato M, Mizuki A, Hayashi T, et al. Cowden’s disease diagnosed through mucocutaneous lesions and gastrointestinal polyposis with recurrent hematochezia, unrevealed by initial diagnosis. Intern Med 2000;39(7):559-63. 40. McGarrity TJ, Wagner Baker MJ, Ruggiero FM, et al. GI polyposis and glycogenic acanthosis of the esophagus associated with PTEN mutation positive Cowden syndrome in the absence of cutaneous manifestations. Am J Gastroenterol 2003;98(6):1429-34. 41. Iacobas I, Burrows PE, Adams DM, Sutton VR, Hollier LH, Chintagumpala M. Oral Rapamycin in the treatment of patients with hamartoma syndromes and PTEN mutation. Pediatr Blood Cancer 2011;57:321-3. 42. Marsh DJ, Trahair T, Martin JL, et al. Rapamycin treatment for a child with germline PTEN mutation. Nat Clin Pract Oncol 2008;5: 357-61. 43. Nawashiro H, Shinomiya N. Everolimus and giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 2011;364(6):576-7. 44. Groen EJ, Roos A, Muntinghe FL, et al. Extra- intestinal manifestations of familial adenomatous polyposis Ann Surg Oncol 2008;15(9): 2439-50. 45. Bisgaard ML, Fenger K, Bülow S, Niebuhr E, Mohr J. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat 1994;3:121-5. 46. European Medicines Agency Doc. Ref.: EMEA/COMP/264/04draft.http://www. emea.europa.eu/pdfs/human/comp/opinion/ 026404en.pdf. 47. Bianch KL, Buerke CA, Bennett AE, Lopez R, Hasson H, Church JM. Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol 2008;6:180-5. 48. Hirschman BA, Pollock BH, Tomlinson GE. The spectrum of APC mutations in children with hepatoblastoma from familial adenomatous polyposis kindreds. J Pediatr 2005; 147:263-6. 49. Bjork J, Akerbrant H, Iselius L, et al. Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology 2001;121:1127-35. 50. Fotiadis C, Tsekouras DK, Antonakis P, Sfiniadakis J, Genetzakis M, Zografos GC. Gardner’s syndrome: A case report and review of the literature. World J Gastroenterol 2005;11 (34):5408-11. 51. Nieuwenhuis MH, Vasen HF. Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. Crit Rev Oncol Hematol 2007;61(2):153-61. 52. Wallis YL, Macdonald F, Hultén M, et al. Genotype phenotype correlation between position of constitutional APC gene mutation and CHRPE expression in FAP. Hum Genet 1994: 5:543-8. 53. Bisgaard ML, Bülow S. Familial adenomatous polyposis (FAP): genotype correlation to FAP phenotype with osteomas and sebaceous cysts. Am J Med Genet 2006:140A:200-4. 54. Vasen HF, Möslein G, Alonso A, et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 2008;57: 704-13. 55. Munck A, Gargouri L, Alberti C, et al. Evaluation of Guidelines for management of familial adenomatous polyposis in a multicenter pediatric cohort. J Pediatr Gastroenterol Nutr 2011;53(3):296-302. 56. Aziz O, Athanasiou T, Fazio VW, et al. Meta- analysis of observational studies of ileorectal versus ileal pouch-anal anastomosis for familial adenomatous polyposis. Br J Surg 2006; 93:407-17. 57. Alkhouri N, Franciosi JP, Mamula P. Familial adenomatous polyposis in children and adolescents. J Pediatr Gastroenterol Nutr 2010;51:727-32. 58. Manfredi M. Hereditary hamartomatous polyposis syndrome: understanding the disease risks as children reach adulthood. Gastroenterol Hepatol 2010;6(3):185-96.

Corrispondenza: pierobon.chiara@gmail.com